[The effects of cytostatic agents on short-term cultures (3H-uridine incorporation) and tissue cultures (cell counts) from human tumors (author's transl)].
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology; D002452:Cell Count; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002478:Cells, Cultured / Q000187:drug effects*; D003561:Cytarabine / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008722:Methods; D008727:Methotrexate / Q000494:pharmacology; D009369:Neoplasms / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000378:metabolism; D011033:Podophyllin / Q000494:pharmacology; D013535:Suspensions; D013997:Time Factors; D014228:Triaziquone / Q000494:pharmacology; D014316:Tritium; D014529:Uridine / Q000378:metabolism*
D000970:Antineoplastic Agents; D013535:Suspensions; D003561:Cytarabine; D014316:Tritium; D001761:Bleomycin; D003609:Dactinomycin; D004317:Doxorubicin; D011033:Podophyllin; D014228:Triaziquone; D005472:Fluorouracil; D014529:Uridine; D008727:Methotrexate; D003630:Daunorubicin
Cytostaticawirkungen auf Kurzzeit-(3H-Uridineinbau) und Gewebekulturen (Zellzah) menschlicher Tumoren